Actinium Pharmaceuticals (ATNM) Current Leases (2019 - 2026)
Actinium Pharmaceuticals (ATNM) posted Current Leases of $5,000 for Q2 2026, down 54.5% from $11,000 a year earlier and down 37.5% from the prior quarter.
Powered by 
Analysis
Actinium Pharmaceuticals (ATNM) Current Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Actinium Pharmaceuticals' Current Leases came in at $11,000, unchanged from FY2024.
- Annual Current Leases shows a five-year compound annual growth rate of -33.6% (FY2020 to FY2025).
- In prior years, Actinium Pharmaceuticals' Current Leases was $11,000 in FY2024 (unchanged), $11,000 in FY2023 (+175.0%), $4,000 in FY2022 (-93.5%) and $62,000 in FY2021 (-27.1%).
- The Q2 2026 figure stands as the lowest quarterly Current Leases since Q3 2023.
- The strongest year-over-year quarter for Current Leases in the past five years was Q2 2024, with growth of 450.0%; the weakest was Q3 2022, with a decline of 95.2%.
- According to Business Quant data, Current Leases for the three prior quarters was $8,000 (Q1 2026), $11,000 (Q4 2025) and $11,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 274.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -2.32 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Actinium Pharmaceuticals | 37.10 Mn | 37.10 Mn | - | 5,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5,000.00 |
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | 11,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | 11,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | 3,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 19,000.00 |
| Mar 31, 2022 | 41,000.00 |
| Dec 31, 2021 | 62,000.00 |
| Sep 30, 2021 | 84,000.00 |
API Access
Actinium Pharmaceuticals Current Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-leases&ticker=ATNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-leases", "ticker": "ATNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-leases&ticker=ATNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();